IREN proposes $875 million convertible notes offering due 2031
Investing.com -- German medical-technology company Ottobock is seeking a valuation of up to €4.2 billion ($4.92 billion) for its initial public offering on the Frankfurt Stock Exchange, scheduled for October 9.
The company announced Monday that shares will be offered at a price range of €62 to €66 per share, with a target offer volume between €766 million and €808 million.
The IPO will primarily consist of a secondary offering from existing stakeholder Naeder Holding, along with approximately €100 million in gross proceeds from new shares, as previously disclosed earlier this month.
According to Monday’s announcement, the offering will include 1.6 million newly issued shares and 9.1 million existing bearer shares from Naeder.
At the proposed price range, Ottobock would achieve a market capitalization between €4 billion and €4.2 billion upon listing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.